Treatment with Cana at 10 mg/kg and 20 mg/kg reduced AFP levels to 52.7% and 21.2% of the HCC group, respectively, with the high dose showing a more significant reduction (p ≤ 0.05). Here, AFP is linked to hepatocellular carcinoma.